Artiria: ARTIRIA Medical raises CHF 3 million to improve stroke treatments

ARTIRIA Medical, an EPFL spin-off and neurovascular start-up closed a CHF 3M Series A financing to bring its first product through clinical validation and regulatory approval. The investment round, led by 4FO Venture Partners, was joined by investiere, the Zürcher Kantonal Bank (ZKB), NEST pension fund, Venture Kick and business angels. In our interview, Guillaume Petit-Pierre, ARTIRIA's Founder and CEO, talks about the steps he went through to achieve this milestone and the objectives of his company.